The objectives of this study were to examine the diversity of Staphylococcus spp. recovered from bovine intramammary infections and humans working in close contact with the animals and to evaluate the susceptibility of the staphylococcal isolates to different antimicrobials. A total of 3,387 milk samples and 79 human nasal swabs were collected from 13 sampling sites in the KwaZulu-Natal province of South Africa. In total, 146 Staph. aureus isolates and 102 coagulasenegative staphylococci (CNS) were recovered from clinical and subclinical milk samples.
genetic elements, which can be exchanged between bacteria of the same or different species occupying the same ecological niche (Lindsay and Holden, 2006) . This is of great clinical significance, as the transfer of resistance genes can lead to the emergence of more resistant and virulent bacterial strains (Lindsay and Holden, 2006) . Although less pathogenic than Staph.
aureus, CNS often exhibit greater resistance to antimicrobials and also have a greater tendency to develop multidrug resistance (MDR) (Taponen and Pyörälä, 2009 ). The CNS are believed to serve as reservoirs of antimicrobial resistance genes, which can transfer and integrate into the genome of Staph. aureus (Otto, 2013; Vital et al., 2014) .
Evaluating the antimicrobial susceptibility of staphylococcal isolates recovered from IMI is important to guide therapeutic treatment of infected animals (Barkema et al., 2006) . Moreover, monitoring the antimicrobial resistance of Staphylococcus spp. in animals is important from a public health perspective. The close proximity of humans and animals in the dairy environment, presents opportunities for the transmission of bacteria between animal and human hosts (Juhász-Kaszanyitzky et al., 2007) . The recent description of livestock-associated methicillin-resistant Staph. aureus (LA-MRSA) (Graveland et al., 2011) and Staph. aureus strains harboring a novel methicillin-resistance gene, mecC (García-Álvarez et al., 2011) , have renewed public concerns regarding the role of animals, particularly livestock, as a reservoir and source of antimicrobial resistant bacteria, which can infect humans (Fitzgerald, 2012) . Both LA-MRSA and Staph. aureus strains harboring the mecC gene have been recovered from bovine milk samples in several studies (Vanderhaeghen et al., 2010; Garcia-Álvarez et al., 2011; Unnerstad et al., 2013) . Inasmuch as the zoonotic transfer of bacteria is of concern from a human health perspective, the reverse scenario -the anthroponotic transfer of bacteria from humans to animals -warrants equal consideration (Fitzgerald, 2012) . It is therefore important that bacterial populations at the animal-human interface should be monitored.
Antimicrobial-resistant Staph. aureus, particularly methicillin-resistant Staph. aureus (MRSA), represent a significant public health burden in both hospital and community settings worldwide (Chambers and DeLeo, 2009 ). The treatment options for infected patients are complicated by the fact that MRSA strains are MDR owing to the carriage of other resistance genes on the cassette chromosome harboring the mecA gene (Holmes and Zadoks, 2011) . Resistance to frontline antimicrobials such as the glycopeptide vancomycin has been documented and the alarming lack of new antimicrobials is a cause of great concern (Pantosti et al., 2007) . Significant efforts are therefore aimed at conserving existing antimicrobials by promoting good antimicrobial stewardship in both human healthcare and veterinary medicine (Morley et al., 2005) .
The purpose of this research was to investigate the diversity of Staphylococcus spp. responsible for IMI in South African dairy cows and to assess the susceptibility of the different species to antimicrobials commonly used in the veterinary field as well as antimicrobials relevant to human medicine. Concomitantly, individuals working in close contact with the animals were sampled and the diversity and susceptibility profiles of staphylococcal isolates determined and compared with the staphylococcal species of animal origin.
MATERIALS AND METHODS

Sample collection and processing
Ethical clearance for this investigation was obtained from the Animal Ethics Committee, Faculty of Veterinary Science, University of Pretoria (H010-13) and the University of Pretoria, Faculty of Health Sciences Research Ethics Committee (No.295/2013 ).
KwaZulu-Natal (KZN) is one of the nine provinces in the Republic of South Africa. Commercial dairy herds (n = 9; identified by the letters A, B, C, E, F, G, I, J and L), communal animal herds (n = 2; collectively identified by the letter M), and agriculture college herds (n = 2; identified by the letters D and H) in KZN were recruited to participate in this study through private and state veterinarians in the province. Participation was voluntary. For commercial dairy herds, the sole criterion for inclusion in this study was a history of staphylococcal mastitis. Because of the limited number of agriculture college herds in the province and the limited accessibility to communal animals, no specific selection criteria could be implemented. Herd sizes ranged from 95 to 1,450 (commercial herds), 40 to 50 (agriculture college herds), and 3 to 8 (communal animals). A single sampling was carried out at each site between October 2013 and March 2014.
Milk samples were aseptically collected into sterile sample tubes following cleaning and disinfection of the teat ends and stripping of the first 2 to 3 squirts of milk. At each of the sampling sites, close contact workers including, animal owners, dairy laborers and veterinary practitioners were approached and asked to participate in the study by providing a self-collected nasal swab (Copan, Brescia, Italy) . Following collection, all milk samples and nasal swab specimens were packed on ice and transported to the laboratory. 
Microbiological analysis of milk samples and nasal specimens
Ten microliters of each milk sample was inoculated onto one quadrant of a Columbia blood agar plate (Oxoid, Basingstoke, UK) supplemented with 5% ovine blood. Culture plates were incubated (NuAire, Plymouth, MN) at 37°C for 48 h. Nasal specimens were transferred to brain heart infusion broth (Oxoid) and incubated at 37°C overnight before being streaked onto Columbia blood agar (Oxoid) supplemented with 5% ovine blood, BBL Columbia nalidixic acid agar (Becton Dickinson, Sparks, MD) and oxacillin-resistance screening agar base (Oxoid). All plates were incubated at 37°C for 48 h before being examined for the presence of staphylococcallike colonies (Quinn et al., 1999) . Preliminary testing of staphylococcal isolates included Gramstaining and testing for catalase production. All catalase-positive, gram-positive coccus-shaped bacterial isolates were tentatively identified as Staphylococcus spp. and tested for coagulaseproduction using rabbit plasma (Bio-Rad, Hercules, CA) and clumping factor using a commercial latex agglutination kit (Pastorex StaphPlus kit, Bio-Rad) (Quinn et al., 1999) .
Only staphylococcal isolates recovered from milk samples with a somatic cell count ≥ 200,000 cells/mL were selected for further characterization. Additional selection criteria for CNS included the occurrence of isolates in pure growth and the presence of 5 or more colonies (≥ 500 cfu/ml milk) on primary culture. When more than one type of CNS was isolated from different quarters of the same cow, based on phenotypic appearance, both isolates were retained for further testing. With respect to the staphylococcal isolates recovered from the human nasal swabs, all Staph. aureus isolates were retained along with representative CNS colonies from each individual. All isolates were stored in 25% glycerol (Merck, Darmstadt, Germany) at -80°C (NuAire) until required.
Identification of staphylococci and screening for mecA and pvl genes using PCR One or two bacterial colonies were suspended in 50 µL sterile deionized water. Bacterial DNA was extracted using the DNeasy blood and tissue kit (Qiagen, Hilden, Germany) in accordance with the manufacturer's instructions. All staphylococcal isolates were amplified using a multiplex PCR assay (multiplex 1) to confirm genus identification, to identify Staph. aureus Details of all oligonucleotide primers and PCR controls are summarized in Table 1 . The PCR products were resolved in a 1.5% agarose gel (SeaKem, Lonza, Rockland, ME), in 1X Tris- (2003) 1 All primers were synthesized by Inqaba Biotechnical Industries (Pretoria, South Africa).
2 Verified field isolateclavulanic acid; FOX = cefoxitin; KF = cephalothin; TET = tetracycline; SXT = trimethoprim and sulfamethoxazole; MXF = moxifloxacin; DA = clindamycin; E = erythromycin; GEN = gentamicin; S = streptomycin; FD = fusidic acid; LZD = linezolid; CPT = ceftaroline borate-EDTA (TBE) buffer (Melford, Ipswich, UK). Following staining in a 1 µg/mL ethidium bromide solution (BioRad) the PCR products were visualized and documented (UVIPro, Uvitec, Cambridge, UK).
Speciation of coagulase-negative staphylococci using PCR, MALDI-TOF MS and tuf gene sequencing
Following genus-specific identification, CNS were identified to species level using a combination of methods. All test isolates were amplified using 1 of 2 multiplex PCR assays (multiplex 2 and 3) based on the origin of the isolates. Reactions were prepared in 25-µL volumes using the Qiagen Multiplex PCR kit and amplified according to the manufacturer's instructions. The PCR products were analyzed as described above with the exception that a 1.8% agarose gel (SeaKem, Lonza) was used to resolve the PCR amplicons.
With the exception of one bovine CNS isolate that failed to grow, overnight cultures of all isolates were preserved in chromatography-grade ethanol (Merck) and submitted for MALDI-TOF MS analysis (Bruker Daltonics GmbH, Bremen, Germany). Coagulase-negative staphylococcal isolates that could not be identified using the multiplex-PCR assay or MALDI-TOF MS or where discordant species identifications were obtained using the 2 methods were analyzed further using tuf gene sequencing. The tuf gene was amplified according to the method described by Heikens and coworkers (2005) , and PCR amplicons were submitted to Inqaba Biotechnical Industries (Pretoria, South Africa) for sequencing. Consensus sequences were analyzed in GenBank and cut-off values for the percentage of identity were adjusted to ≥ 97% sequence similarity.
Antimicrobial susceptibility testing of staphylococcal isolates
The antimicrobial susceptibility of the staphylococcal test isolates to 15 antimicrobials was (Fiebelkorn et al., 2003) . A control isolate,
Staph. aureus ATCC 25923, was tested together with each batch of field isolates to ensure the validity of the test results. The zone measurements for all antimicrobials, with the exception of fusidic acid and streptomycin, were compared with CLSI breakpoints based on data derived from human medicine (CLSI, 2008 (CLSI, , 2014 . In the case of fusidic acid, the breakpoint recommended by the European committee on Antimicrobial Susceptibility Testing (EUCAST, 2014) was used and for streptomycin a breakpoint of ≥ 14 mm was used as described by Kim and coworkers (2004) and Shittu and Lin (2006) . The production of β-lactamase by Staph. aureus isolates was determined by examining the edge of the zone of inhibition surrounding the pencillin disk.
Isolates showing abrupt, heaped edges were recorded as being resistant to penicillin, irrespective of the zone diameter (CLSI, 2014). Beta-lactamase production by CNS isolates was determined using nitrocefin-impregnated sticks (Oxoid) in accordance with the manufacturer's instructions.
Resistance categories were defined based on recommendations made by Schwarz and coworkers (2010) . Briefly, isolates showing susceptibility to all classes of antimicrobials tested were termed pansusceptible; isolates showing resistance to 1 or 2 classes of antimicrobials were termed resistant and isolates showing resistance to 3 or more classes of antimicrobials were termed multidrug-resistant (MDR).
PCR screening of staphylococcal isolates for antimicrobial resistance determinants
Staphylococcal isolates were screened for a combination of 7 antimicrobial resistance genes using 2 multiplex-PCR assays. Reactions were prepared in 25-µL volumes using the Qiagen Multiplex PCR kit and included primers specific for the blaZ, mecC, vanA and vanB (multiplex 4) and tetK, tetM and aacA-aphD (multiplex 5) genes. Amplification of PCR reactions was carried out in a MJ Mini thermocycler (BioRad) using the thermocycling conditions recommended by the kit manufacturer. Electrophoresis was carried out as described above.
RESULTS
Microbiological analysis
A total of 3,387 milk samples, from 1,374 cows, and 79 human nasal swab specimens were collected from 13 dairy herds. One hundred and forty-six Staph. aureus and 102 CNS isolates cultured from the milk samples fulfilled the selection criteria and were retained for further analysis. Staphylococcus aureus was recovered from 12 (15.2%) of the human nasal swabs. All 12 Staph. aureus isolates and the 95 CNS isolates recovered from the nasal swabs were retained for analysis.
Identification of staphylococci and screening for mecA and pvl genes by PCR
All of the analyzed staphylococcal isolates were genotypically identified as Staphylococcus spp.
using the first multiplex-PCR assay. Furthermore, all of the isolates phenotypically identified as A further 9 CNS were analyzed using tuf gene sequencing in order to confirm the species identification obtained using MALDI-TOF MS. The percentage distribution of coagulasenegative Staphylococcus species isolated from both the milk samples and human specimens is presented in 
Antimicrobial susceptibility testing of staphylococcal isolates
All staphylococcal isolates were evaluated for susceptibility to antimicrobials used for the treatment of bovine IMI as well as antimicrobials relevant to human medicine. The antimicrobial susceptibility profiles of the Staph. aureus isolates of bovine and human origin are summarized in Table 4 . None of the CNS isolates of human origin showed phenotypic resistance to cephalothin or linezolid. The 15 human CNS isolates, which tested positive for the presence of the mecA gene using the first multiplex-PCR assay, and were subsequently identified as Staph.
epidermidis (n = 12) and Staph. haemolyticus (n = 5), were found to be phenotypically resistant to cefoxitin.
PCR screening of staphylococcal isolates for antimicrobial resistance determinants
The blaZ gene was detected in 172 of the 355 (48.5%) staphylococcal isolates examined. All 172
isolates had been found to be resistant to penicillin when tested phenotypically. Two isolates, 1
Staph. sciuri (human origin) and 1 Staph. chromogenes (bovine origin), that were found to be phenotypically resistant to penicillin did not test positive for the blaZ gene using the multiplex PCR assay. None of the staphylococcal isolates tested positive for the presence of the tetM gene. 
Number of isolates in parentheses 3 PEN = penicillin; AMP = ampicillin; AMC = amoxicillin/clavulanic acid; FOX = cefoxitin; KF = cephalothin; TET = tetracycline; SXT = trimethoprim and sulfamethoxazole; MXF = moxifloxacin; DA = clindamycin; E = erythromycin; GEN = gentamicin; S = streptomycin; FD = fusidic acid; LZD = linezolid;
The tetK gene was detected in 76 of the 79 (96.2%) isolates which were phenotypically resistant to tetracycline. Three of the staphylococcal isolates that were phenotypically resistant to tetracycline did not carry either the tetK or tetM genes. Nine isolates of human origin (4 Staph. epidermidis, 5 Staph. haemolyticus) tested positive for the presence of the aminoglycoside resistance determinant aacA-aphD. None of the bovine isolates were found to be carrying this specific gene. None of the staphylococcal isolates were positive for the mecC gene or the vancomycin resistance determinants vanA and vanB.
DISCUSSION
Staphylococci are a common cause of bovine IMI worldwide, including South Africa (Petzer et al., 2009 ). This study was not designed to carry out a prevalence study but rather to facilitate the collection of a representative number of staphylococcal isolates from different dairy operations in KZN for further characterization. Consequently, the selection of participating commercial dairy herds was based on the criterion that each of the herds had a history of IMI caused by Staphylococcus spp.
A combination of methods was used to identify the CNS isolates of bovine and human origin.
This approach was used in order to improve the accuracy of bacterial identification at the species level. The predominant CNS species recovered from the milk samples analyzed in this study was Staph. chromogenes, which accounted for 78.4% of the isolates examined. The proportion of different Staphylococcus species recovered from bovine IMI has varied between studies carried out in different countries. In general, Staph. chromogenes, Staph. haemolyticus, Staph. epidermidis, Staph. simulans and Staph. xylosus are usually among the most commonly isolated species (Vanderhaegen et al., 2015) . In Sweden, Persson-Waller and coworkers (2011) found Staph. chromogenes (24%) and Staph. epidermidis (22%) to be the most common CNS species identified amongst a collection of isolates assembled from 2 national mastitis surveys. A study in Switzerland reported Staph. xylosus (36.0%) and Staph. chromogenes (16.8%) to be among the most common CNS causing mastitis (Frey et al., 2013) . In the United States, Park and coworkers (2011) identified 11 CNS species from cases of mastitis, with Staph. chromogenes (72.2%), Staph. xylosus (9.1%), and Staph. haemolyticus (6.1%) being the most common species identified. It has been suggested that the distribution of CNS species causing IMI is herd-specific and may be influenced by specific management practices that may vary between countries (Thorberg et al., 2009; Supré et al., 2011) . Species-level epidemiological studies conducted in European dairy herds have shown that Staph. chromogenes is a more specific udder pathogen than other CNS and tends to cause persistent IMI (Supré et al., 2011) . Staphylococcus chromogenes was also found to have a significant effect on the SCC of infected quarters, comparable to counts induced by Staph. aureus infections (Supré et al., 2011) .
Five of the CNS isolates remained unidentified following PCR, MALDI-TOF MS and sequencing of the tuf gene. All 5 of the isolates had the same tuf gene sequence and in all likelihood are the same species. The tuf gene sequence showed 99% to 100% similarity with sequence data deposited by Capurro and coworkers (2009) , which interestingly belonged to an isolate recovered from mastitic milk samples in Finland. In recent years, several new Staphylococcus species have been described. Supré and coworkers (2010) 
described a novel
Staphylococcus species, Staph. devriesei, which had been isolated from bovine teat apices as well as milk from study herds in Belgium and The Netherlands. Taponen and coworkers (2012) published details describing a new, previously unidentified Staphylococcus species, named Staph. agnetis. Isolates representing this newly described species were recovered from bovine milk samples (Taponen et al., 2012) . Further genotyping studies will be undertaken to identify the unidentified Staphylococcus spp. recovered from the milk samples analyzed in the current study.
The predominant CNS recovered from the human nasal swab samples was Staph. epidermidis. This is not surprising as Staph. epidermidis is a known commensal forming part of the natural microflora on human skin (Thorberg et al., 2006) . Molecular typing studies conducted by Thorberg and coworkers (2006) in Sweden showed that Staph. epidermidis isolates recovered from cases of mastitis were genotypically identical to isolates recovered from the skin of milkers.
This observation led them to suggest that Staph. epidermidis is a zoonotic organism. In contrast to the high prevalence of Staph. epidermidis in the human swab samples analyzed in this study, only one of the bovine isolates tested was identified as Staph. epidermidis. This may indicate that Staph. epidermidis is not a significant causative agent of IMI in our study area.
Overall, 15.2% of the humans sampled in this study were found to harbor Staph. aureus. It is reported that approximately 20% of healthy human individuals are persistent carriers of Staph. aureus, 30% are intermittent carriers, and 50% of individuals are never colonized by Staph. aureus (Kluytmans and Streulans, 2009; Graveland et al., 2011) . Nasal carriage of Staph.
aureus is recognized as a risk factor for acquiring infections and additionally plays a role in the dissemination of Staph. aureus in hospitals and the community (Zriouil et al., 2012) .
The β-lactam antibiotics penicillin and ampicillin are used extensively for the prevention and treatment of IMI in dairy cows (IVS, 2015) . In South Africa, more than half of the intramammary preparations available for use comprise penicllin or ampicillin with or without dihydrostreptomycin (IVS, 2015) . Furthermore, many of the preparations are available to farmers over the counter, making it difficult to monitor and control antimicrobial usage. In our study, resistance to penicillin was the most commonly detected resistance, with 28.8% of the Staph. aureus and 37.3% of CNS isolates showing phenotypic resistance to penicillin. This scenario parallels reports from other countries. Pyörälä and coworkers (2011) indicated that generally between one-third and two-thirds of bovine Staph. aureus isolates are resistant to penicillin, with lower percentages being reported in countries where strict antimicrobial policies have been implemented. Differences in the levels of bacterial resistance documented between studies are influenced by sampling strategies and bacterial populations but also differences in test methodology and the use of different interpretation criteria (Barkema et al., 2006) . It is therefore suggested that comparisons between studies be restricted to studies that have used the same methodology and interpretation criteria (Schwarz et al., 2010) .
It is of great significance, from both an animal and a public health perspective, that none of the staphylococcal isolates of bovine origin exhibited resistance to cefoxitin, the in vitro surrogate for examining the phenotypic susceptibility of isolates to methicillin (CLSI, 2014) . Several studies have reported on the presence of methicillin-resistant staphylococci in milk samples, raising concerns over milk as a source of methicillin-resistant bacteria. In Switzerland, 47% of the CNS isolates evaluated in vitro, were found to be resistant to oxacillin (Frey et al., 2013) . Vanderhaeghen and co-workers (2010) found that almost 10% of herds sampled in Belgium to have cases of mastitis caused by MRSA. The in-herd prevalence of MRSA varied between 0 and 7.4%. Furthermore, all strains had characteristics typical of the zoonotic LA-MRSA strains belonging to clonal complex (CC) 398.
In South Africa, antimicrobial susceptibility data are sparse. Three studies have reported on the occurrence of MRSA from cases of bovine mastitis with prevalence rates varying between 1.1% and 93.2% (Petzer et al., 2007; Ateba et al., 2010; Schmidt, 2011) . The high prevalence of 93.2% noted in one study is largely attributable to the sampling approach and the small sample size (Ateba et al., 2010) . None of the studies confirmed the presence of the mecA gene in the isolates exhibiting phenotypic resistance. Generally, it is accepted that screening for the mecA gene is the most reliable method for the detection of methicillin resistance in staphylococcal isolates. Performing only phenotypic tests has previously led to the reporting of both false positive and false negative results (Vanderhaeghen et al., 2010) .
Phenotypic resistance to antimicrobials other than penicillin and ampicillin was not common among the bovine staphylococcal isolates evaluated in our study. A low percentage of Staph. aureus (8.2%) and CNS (4.9%) isolates exhibited phenotypic resistance to streptomycin.
Resistance to tetracycline was also noted, with 2.7% of the Staph. aureus and 8.8% of the CNS isolates showing phenotypic resistance to this antimicrobial. The observed resistance coincides with the availability of both of these antimicrobials in intramammary preparations in South Africa (IVS, 2015) . None of the bovine Staph. aureus or CNS isolates exhibited resistance to cephalothin, clindamycin, erythromycin, linezolid or moxifloxacin, and only 2 isolates, 1 Staph. hyicus and 1 Staph. xylosus, were found to be phenotypically resistant to fusidic acid. The aforementioned antimicrobials have limited application in veterinary medicine but are used in human medicine to treat different types of staphylococcal infections (Lowy, 2013) .
Multidrug resistance was more common among the CNS than the Staph. aureus isolates and more common among human isolates than bovine isolates. In total, 37 (39%) of the CNS isolates of human origin were MDR, whereas only 2 Staph. chromogenes isolates of bovine origin were MDR. Two Staph. aureus isolates of bovine origin were MDR, whereas only a single Staph. aureus isolate from the human nasal swabs was found to be MDR. Interestingly, the human MDR Staph. aureus was isolated from a farm laborer on the same farm as the MDR bovine Staph. aureus isolate and displayed the same antimicrobial susceptibility profile. Future genotyping studies will be undertaken to determine the genetic relatedness of the bovine and human isolates and investigate possible bacterial transmission between hosts.
Antimicrobial susceptibility testing of isolates was supplemented by screening for specific antimicrobial resistance genes. None of the staphylococcal isolates evaluated were shown to carry the vanA and vanB genes, which confer vancomycin resistance to isolates. Considering the importance and reliance on vancomycin for the treatment of MRSA infections in human medicine, the lack of vancomycin resistance markers in both the bovine and human staphylococci analyzed in our study is therefore positive.
The correlation between the phenotypic susceptibility of isolates to pencillin with the presence of the blaZ gene was not absolute. A Staph. sciuri isolate of human origin and a Staph. chromogenes isolate of bovine origin were found to be phenotypically resistant to penicillin but negative for the presence of the blaZ gene. A possible explanation for this discrepancy could be a mutation of the primer-annealing site that prevented amplification. All staphylococcal test isolates were also screened for the presence of 2 tetracycline resistance determinants: tetK and tetM. The tetK gene was detected in the majority of the isolates showing phenotypic resistance to tetracycline, whereas tetM was not detected. Three isolates, two Staph. chromogenes and 1 Staph. haemolyticus, that were phenotypically resistant to tetracycline tested negative for the presence of both tetK and tetM. This discrepancy could be due to the presence of other tetracycline resistance encoding genes, such as tetL or tetO, or due to a mutation in the primer-annealing site. The discrepancies observed between the phenotypic susceptibility of our test isolates and PCR screening for resistance genes highlight some of the shortcomings associated with the molecular detection of antimicrobial resistance. In many cases, antimicrobial resistance can be mediated by a number of different genes and mechanisms, some of which are still undescribed (Fluit, 2001 ).
One of the specific limitations associated with the determination of the antimicrobial susceptibility of veterinary bacterial isolates is the fact that there are currently very few antimicrobial breakpoints validated specifically for use with isolates of veterinary origin (Schwarz et al., 2010) . At present, interpretive data are only available for the testing of mastitis pathogens against ceftiofur, penicillin-novobiocin and pirlimycin (CLSI, 2008) . The latter antimicrobial is currently not registered for use in South Africa (IVS, 2015) . Because of the lack of data, it is common practice to make use of breakpoints derived from human medicine to interpret in vitro data. This is not ideal and should be taken into consideration when interpreting results.
CONCLUSION
This study provides insight into the diversity of Staphylococcus spp. causing IMI in cows in South African dairy herds and communal animals. The predominance of S. chromogenes among the CNS isolates warrants further investigation to elucidate the epidemiology and virulence characteristics of strains circulating within herds. This study further demonstrated that antimicrobial resistance amongst Staphylococcus spp. causing IMI was generally low. These results suggest the responsible usage of antimicrobials on dairy farms or the existence of management practices which do not favor the accumulation of resistance genes, or both. Because of the propensity of staphylococci to acquire antimicrobial resistance through the genetic exchange of DNA with material with compatible strains occupying the same microbiological niche, continued monitoring of bacterial populations is necessary.
